Curapulse Co., Ltd.

Based in Ansan, South Korea, Curapulse Co. , Ltd. specializes in innovative medical and wellness solutions, harnessing technologies like ultrasound and electrical stimulation to enhance cognitive functions and skincare. Curapulse Co.

, Ltd. was founded in 2025 in Ansan, South Korea, by Nam-kyu Cho, who serves as the CEO. The company focuses on advanced medical technologies and wellness solutions, positioning itself as a key player in the market. It has completed one funding deal, with the most recent transaction occurring on September 1, 2025.

Curapulse Co. , Ltd. specializes in advanced medical and wellness solutions that leverage innovative technologies such as ultrasound, electrical stimulation, and LED. Their core product offerings include neuromodulation platforms like SB BrainStim™ and BrainSync™, aimed at improving cognitive functions such as focus, stress reduction, sleep enhancement, and memory support.

Additionally, in the skincare sector, Curapulse provides rejuvenation solutions through proprietary technologies like DualTetra WaveSync™, DualPoration™, and IntraSonix™, which work by combining ultrasound, pulse wave, and phototherapy to improve skin elasticity and combat aging. The company's products are marketed globally, targeting various consumer segments, including healthcare providers, wellness clinics, and individual consumers seeking both home and professional skincare and cognitive enhancement solutions. Curapulse operates on a business model characterized by both direct-to-consumer and B2B transactions, enabling the company to reach a diverse clientele. Revenue streams are generated through the sale of its innovative devices, including flagship products like SB BrainStim™ and DualTetra WaveSync™.

The company partners with wellness clinics and healthcare providers, facilitating bulk purchases and potentially establishing subscription models for ongoing support and product updates. Additionally, Curapulse offers OEM and ODM services, allowing other brands to leverage their proprietary technologies in customized solutions. By fostering partnerships and direct sales, Curapulse effectively capitalizes on various distribution channels, ensuring broad market penetration and consumer engagement across multiple geographical regions. In September 2025, Curapulse Co.

, Ltd. raised an undisclosed amount in Seed funding from New Paradigm Investment. The company plans to utilize this funding to enhance its technology and expand into foreign markets. Curapulse is designing new products aimed at further improving its offerings and has strategies in place to penetrate additional geographic regions to broaden its market reach.